Listed

PharmaCyte Biotech, Inc.: Form 10-Q for the period ended Oct 31, 2011

Filed with the SEC on Dec 15, 2011 and accepted by EDGAR at Dec 15, 2011, 15:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-10-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-08-01 to 2011-10-31$19.8kus-gaap:Revenues
Revenue6 months2011-05-01 to 2011-10-31$39.6kus-gaap:Revenues
Cost of revenue3 months2011-08-01 to 2011-10-31$6.0kus-gaap:CostOfRevenue
Cost of revenue6 months2011-05-01 to 2011-10-31$21.7kus-gaap:CostOfRevenue
Gross profit3 months2011-08-01 to 2011-10-31$13.8kus-gaap:GrossProfit
Gross profit6 months2011-05-01 to 2011-10-31$17.9kus-gaap:GrossProfit
Interest expense3 months2011-08-01 to 2011-10-31−$33.4kus-gaap:InterestExpense
Interest expense6 months2011-05-01 to 2011-10-31−$66.8kus-gaap:InterestExpense
Net income3 months2011-08-01 to 2011-10-31−$437.2kus-gaap:NetIncomeLoss
Net income6 months2011-05-01 to 2011-10-31−$1.1mus-gaap:NetIncomeLoss
Basic EPS3 months2011-08-01 to 2011-10-31$0.00us-gaap:EarningsPerShareBasic
Basic EPS6 months2011-05-01 to 2011-10-31$0.00us-gaap:EarningsPerShareBasic
Operating cash flow6 months2011-05-01 to 2011-10-31−$171.2kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2011-10-31$14.5kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-10-31$606.5kus-gaap:AssetsCurrent
Total assetsAt period end2011-10-31$1.7mus-gaap:Assets
Current liabilitiesAt period end2011-10-31$3.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-10-31$3.5mus-gaap:Liabilities
Short-term borrowingsAt period end2011-10-31$2.4mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2011-10-31−$2.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001262463-11-000325. Last ingested by Listed: Nov 14, 2026, 20:52 ET. Listed shows no prices and gives no investment advice.